Skip to Content

AUGTYRO 40 mg hard capsules

Licence status
Authorised: 13/01/2025
Active substances
Repotrectinib
Dosage Form
Capsule, hard
Licence number
EU/1/24/1883/001-002
Licence holder
Bristol-Myers Squibb Pharma EEIG

Licence information

ATC code
L01EX28 repotrectinib
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
13/01/2025